How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults

Br J Haematol. 2018 Sep;182(5):621-632. doi: 10.1111/bjh.15409. Epub 2018 Aug 17.


The inherited platelet glycoprotein deficiencies, Glanzmann thrombasthenia (GT) and Bernard Soulier syndrome (BSS) are rare but important long-term bleeding disorders. Once diagnosed, affected patients should be referred to a specialist centre for bleeding disorders for general advice and ongoing management. Patients do not require prophylactic treatment and so the management of GT and BSS focuses around prophylactic treatment prior to high risk procedures and treatment in response to non-surgical bleeding events and, in women, the management of menorrhagia and pregnancy. There is no consistent approach to the treatment or prevention of bleeding complications. Management must be tailored for each individual and the approach may not be the same for different events, even for the same patient, depending on the type of accident or invasive procedure, the extent of bleeding and the presence or not of platelet refractoriness.

Keywords: bernard soulier syndrome; glanzmann thrombasthenia; management; menorrhagia; pregnancy.

Publication types

  • Review

MeSH terms

  • Adult
  • Bernard-Soulier Syndrome / pathology*
  • Bernard-Soulier Syndrome / therapy
  • Child
  • Disease Management*
  • Female
  • Hemorrhage / etiology
  • Hemorrhage / therapy
  • Humans
  • Male
  • Menorrhagia / etiology
  • Menorrhagia / therapy
  • Platelet Membrane Glycoproteins / deficiency*
  • Precision Medicine / methods
  • Pregnancy
  • Thrombasthenia / pathology*
  • Thrombasthenia / therapy


  • Platelet Membrane Glycoproteins